🔴 Cue Biopharma is trading 5% down today amid sector weakness; company-specific cause unconfirmed

Cue Biopharma is trading 5.01% down at $18.59 on October 14, amid biotech-sector weakness and a broader selloff; no direct cause is confirmed.

• XBI is down 2.01%, while Reuters reported hotter-than-expected September inflation boosted rate-hike bets and weighed on major indexes.
• No confirmed company-specific announcement explaining the decline was identified; Cue Biopharma’s investor-relations page lists positive CUE-221 Phase 2 results, not a new October 14 release.